Niloufa Insanally
General Counsel at OmeCare Ventures, Inc.
Profile
Niloufa Insanally is currently working as a Manager-Regulatory Affairs at OmeCare Ventures, Inc. Prior to this, she worked as a Principal at Integra LifeSciences Holdings Corp., SkyePharma Plc, Gen-Probe, Inc., Enigma Diagnostics Ltd., and as Head-Regulatory Affairs at Irras AB.
She completed her undergraduate degree at the University of Toronto and her doctorate degree at the University of North London.
Niloufa Insanally active positions
| Companies | Position | Start |
|---|---|---|
OmeCare Ventures, Inc.
 OmeCare Ventures, Inc. Miscellaneous Commercial ServicesCommercial Services OmeCare Ventures, Inc. engages in health and wellness industry. It provides fitness, nutrition, skin, mental health DNA insight, pain medication DNA insight, carrier status DNA insight and cannabis DNA products. The company was founded in September 2008 by James Plante and is headquartered in San Diego, CA. | General Counsel | - |
Former positions of Niloufa Insanally
| Companies | Position | End |
|---|---|---|
| IRRAS AB | General Counsel | - |
| SKYEPHARMA PLC | Corporate Officer/Principal | - |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Corporate Officer/Principal | - |
Enigma Diagnostics Ltd.
 Enigma Diagnostics Ltd. Medical SpecialtiesHealth Technology Enigma Diagnostics Ltd. develops next generation rapid molecular diagnostic instrument platforms for decentralized and point-of-care settings. It offers Enigma Instruments, Enigma MiniLab, and Enigma technology and IP. The firm has operation in Salisbury and San Diego. The company was founded in 2004 and is headquartered in Salisbury, the United Kingdom. | Corporate Officer/Principal | - |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Training of Niloufa Insanally
| University of Toronto | Undergraduate Degree |
| University of North London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Health Technology |
| IRRAS AB | Health Technology |
| Private companies | 4 |
|---|---|
OmeCare Ventures, Inc.
OmeCare Ventures, Inc. Miscellaneous Commercial ServicesCommercial Services OmeCare Ventures, Inc. engages in health and wellness industry. It provides fitness, nutrition, skin, mental health DNA insight, pain medication DNA insight, carrier status DNA insight and cannabis DNA products. The company was founded in September 2008 by James Plante and is headquartered in San Diego, CA. | Commercial Services |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
Enigma Diagnostics Ltd.
Enigma Diagnostics Ltd. Medical SpecialtiesHealth Technology Enigma Diagnostics Ltd. develops next generation rapid molecular diagnostic instrument platforms for decentralized and point-of-care settings. It offers Enigma Instruments, Enigma MiniLab, and Enigma technology and IP. The firm has operation in Salisbury and San Diego. The company was founded in 2004 and is headquartered in Salisbury, the United Kingdom. | Health Technology |
SkyePharma Plc
 SkyePharma Plc Pharmaceuticals: OtherHealth Technology SkyePharma Plc engaged in the provision of pharmaceutical business. It involved in development and supply of pharmaceutical products. The company was founded by Ian Roderick Gowrie-Smith on August 18, 1910 and was headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Niloufa Insanally
